Donation

Improving Lives
Improving Lives
Improving Lives
We provide compassionate and proactive outreach. Our patient education, support, and advocacy programs improve the lives of those impacted by myeloma.
Finding the Cure
We push for constant scientific advancements around the world. Our groundbreaking research initiatives are on the cusp of finding a cure for multiple myeloma.
We push for constant scientific advancements around the world. Our groundbreaking research initiatives are on the cusp of finding a cure for multiple myeloma.
Improving Lives and Finding the Cure
Improving Lives

We're Here for You!

The IMF is dedicated to improving the quality of life of myeloma patients while working toward prevention and a cure.

I am a...

Please choose how you best identify to see associated content.
The variants of who I am

A Message From IMF President and CEO Yelak Biru

 

Watch IMF President and CEO—as well as 27-year multiple myeloma survivor—Yelak Biru reflects on the impact of the IMF in 2022 and shares his vision for the future.

 

IMF Board Member and myeloma patient advocate Yelak Biru
Knowledge Is Power: Publications
Explore the IMF's library of publications and other resources.
imf-burgundy
MPower Hub image
M-Power: Changing the Course of Myeloma
Improving the outcomes of African-American patients with multiple myeloma.
sunrise
fathers and children lined up to race outside
Start a Fundraiser
Apply your skills by creating or joining a fundraising campaign
blackberry
Start a Fundraiser for the IMF

Need assistance in creating a fundraiser? The IMF team is here for you. Find out how you can help in the fight against myeloma today! 

Close up of runner's shoes during a marathon
d
Image Left
White
For the Latest Information, Stay in Touch!
Subscribe to the Myeloma Minute for late-breaking news and events.

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.